{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:49:11Z","timestamp":1791607751533,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672887"],"award-info":[{"award-number":["81672887"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81172049"],"award-info":[{"award-number":["81172049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Research Foundation of Luzhou City and Southwest Medical University","award":["2018LZXNYD-YL01"],"award-info":[{"award-number":["2018LZXNYD-YL01"]}]},{"name":"Research Foundation of the Science and Technology Department of Luzhou City"},{"name":"Research Foundation of the Education Department of Sichuan Province","award":["18ZB0647"],"award-info":[{"award-number":["18ZB0647"]}]},{"name":"Research Foundation of Sichuan Science and Technology Innovation Seedling Project","award":["2017056"],"award-info":[{"award-number":["2017056"]}]},{"name":"Macau Science and Technology Development Fund"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.phrs.2019.03.011","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T11:50:15Z","timestamp":1554724215000},"page":"79-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"special_numbering":"C","title":["Cordycepin Inhibits Drug-resistance Non-small Cell Lung Cancer Progression by Activating AMPK Signaling Pathway"],"prefix":"10.1016","volume":"144","author":[{"given":"Chunli","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zebo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianzheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingliang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Lai-Han","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2019.03.011_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"21","key":"10.1016\/j.phrs.2019.03.011_bib0010","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa1715907","article-title":"Higher Lung Cancer Incidence in Young Women Than Young Men in the United States","volume":"378","author":"Jemal","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.phrs.2019.03.011_bib0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrd.2016.42","article-title":"The non-small-cell lung cancer drug market","volume":"15","author":"Nawaz","year":"2016","journal-title":"Nature Reviews Drug Discovery"},{"issue":"8","key":"10.1016\/j.phrs.2019.03.011_bib0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrc3775","article-title":"Non-small-cell lung cancers: a heterogeneous set of diseases","volume":"14","author":"Chen","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"10.1016\/j.phrs.2019.03.011_bib0025","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMct0807960","article-title":"Treatment of non-small-cell lung cancer with erlotinib or gefitinib","volume":"364","author":"Cataldo","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.phrs.2019.03.011_bib0030","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1470-2045(16)30033-X","article-title":"Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial","volume":"17","author":"Park","year":"2016","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.phrs.2019.03.011_bib0035","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/annonc\/mdw611","article-title":"Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial","volume":"28","author":"Paz-Ares","year":"2017","journal-title":"Ann Oncol"},{"issue":"17","key":"10.1016\/j.phrs.2019.03.011_bib0040","doi-asserted-by":"crossref","first-page":"14754","DOI":"10.18632\/oncotarget.4474","article-title":"AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer","volume":"6","author":"Jhaveri","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.phrs.2019.03.011_bib0045","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/JTO.0000000000000241","article-title":"V843I, a Lung Cancer Predisposing EGFR Mutation, Is Responsible for Resistance to EGFR Tyrosine Kinase Inhibitors","volume":"9","author":"Matsushima","year":"2014","journal-title":"Journal of Thoracic Oncology"},{"key":"10.1016\/j.phrs.2019.03.011_bib0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.critrevonc.2016.01.024","article-title":"Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature","volume":"100","author":"van der Wekken","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"10.1016\/j.phrs.2019.03.011_bib0055","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.3892\/ol.2017.5980","article-title":"Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations","volume":"13","author":"Krawczyk","year":"2017","journal-title":"Oncology letters"},{"issue":"1","key":"10.1016\/j.phrs.2019.03.011_bib0060","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/1078-0432.CCR-17-0692","article-title":"Degalactotigonin, a Natural Compound from Solanum nigrum L., Inhibits Growth and Metastasis of Osteosarcoma through GSK3beta Inactivation-Mediated Repression of the Hedgehog\/Gli1 Pathway","volume":"24","author":"Zhao","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.phrs.2019.03.011_bib0065","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nm.2471","article-title":"The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine","volume":"17","author":"Tu","year":"2011","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.phrs.2019.03.011_bib0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jphs.2014.09.001","article-title":"Anticancer and antimetastatic effects of cordycepin, an active component of Cordyceps sinensis","volume":"127","author":"Nakamura","year":"2015","journal-title":"Journal of Pharmacological Sciences"},{"issue":"1","key":"10.1016\/j.phrs.2019.03.011_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13205-013-0121-9","article-title":"Pharmacological and therapeutic potential of Cordyceps with special reference to Cordycepin","volume":"4","author":"Tuli","year":"2014","journal-title":"3 Biotech"},{"issue":"4","key":"10.1016\/j.phrs.2019.03.011_bib0080","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1254\/jphs.10041FP","article-title":"Cordycepin Prevents Hyperlipidemia in Hamsters Fed a High-Fat Diet via Activation of AMP-Activated Protein Kinase","volume":"113","author":"Guo","year":"2010","journal-title":"Journal of Pharmacological Sciences"},{"issue":"1","key":"10.1016\/j.phrs.2019.03.011_bib0085","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12906-016-1278-7","article-title":"Ophiocordyceps formosana improves hyperglycemia and depression-like behavior in an STZ-induced diabetic mouse model","volume":"16","author":"Huang","year":"2016","journal-title":"BMC Complementary and Alternative Medicine"},{"issue":"1","key":"10.1016\/j.phrs.2019.03.011_bib0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejphar.2013.05.049","article-title":"Effects of cordycepin on Y-maze learning task in mice","volume":"714","author":"Cai","year":"2013","journal-title":"European Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2019.03.011_bib0095","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/cns.12060","article-title":"Cordycepin suppresses excitatory synaptic transmission in rat hippocampal slices via a presynaptic mechanism","volume":"19","author":"Yao","year":"2013","journal-title":"CNS Neurosci Ther"},{"issue":"7","key":"10.1016\/j.phrs.2019.03.011_bib0100","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317706915","article-title":"Cordycepin induces apoptosis in human bladder cancer cells via activation of A3 adenosine receptors","volume":"39","author":"Cao","year":"2017","journal-title":"Tumor Biology"},{"issue":"2","key":"10.1016\/j.phrs.2019.03.011_bib0105","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3892\/ol.2015.3273","article-title":"Apoptosis and inhibition of proliferation of cancer cells induced by cordycepin","volume":"10","author":"Tian","year":"2015","journal-title":"Oncology letters"},{"issue":"12","key":"10.1016\/j.phrs.2019.03.011_bib0110","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/ptr.3132","article-title":"Cordycepin suppresses TNF-alpha-induced invasion, migration and matrix metalloproteinase-9 expression in human bladder cancer cells","volume":"24","author":"Lee","year":"2010","journal-title":"Phytother Res"},{"issue":"3","key":"10.1016\/j.phrs.2019.03.011_bib0115","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3892\/ijo.2013.1762","article-title":"Apoptosis induction of human prostate carcinoma cells by cordycepin through reactive oxygen speciesmediated mitochondrial death pathway","volume":"42","author":"Lee","year":"2013","journal-title":"Int J Oncol"},{"issue":"12","key":"10.1016\/j.phrs.2019.03.011_bib0120","doi-asserted-by":"crossref","first-page":"9834","DOI":"10.18632\/oncotarget.3383","article-title":"Cordycepin (3\u2019-deoxyadenosine) suppressed HMGA2, Twist1 and ZEB1-dependent melanoma invasion and metastasis by targeting miR-33b","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.phrs.2019.03.011_bib0125","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1747-0285.2010.01019.x","article-title":"Binding of cordycepin monophosphate to AMP-activated protein kinase and its effect on AMP-activated protein kinase activation","volume":"76","author":"Wang","year":"2010","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.phrs.2019.03.011_bib0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ceb.2017.01.005","article-title":"AMPK signalling in health and disease","volume":"45","author":"Carling","year":"2017","journal-title":"Current Opinion in Cell Biology"},{"issue":"1","key":"10.1016\/j.phrs.2019.03.011_bib0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/BJ20120546","article-title":"AMP-activated protein kinase: new regulation, new roles?","volume":"445","author":"Carling","year":"2012","journal-title":"Biochemical Journal"},{"issue":"7","key":"10.1016\/j.phrs.2019.03.011_bib0140","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.81","article-title":"Regulation and function of AMPK in physiology and diseases","volume":"48","author":"Jeon","year":"2016","journal-title":"Experimental & molecular medicine"},{"issue":"2","key":"10.1016\/j.phrs.2019.03.011_bib0145","first-page":"232","article-title":"Functional characterization of AMP-activated protein kinase signaling in tumorigenesis","volume":"1866","author":"Cheng","year":"2016","journal-title":"Biochimica et biophysica acta"},{"issue":"11","key":"10.1016\/j.phrs.2019.03.011_bib0150","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1021\/acs.molpharmaceut.8b00551","article-title":"Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway","volume":"15","author":"Bi","year":"2018","journal-title":"Molecular Pharmaceutics"},{"issue":"8","key":"10.1016\/j.phrs.2019.03.011_bib0155","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.7150\/ijbs.4458","article-title":"DLX4 upregulates TWIST and enhances tumor migration, invasion and metastasis","volume":"8","author":"Zhang","year":"2012","journal-title":"International journal of biological sciences"},{"issue":"6","key":"10.1016\/j.phrs.2019.03.011_bib0160","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0733-4","article-title":"Proscillaridin A induces apoptosis and suppresses non-small-cell lung cancer tumor growth via calcium-induced DR4 upregulation","volume":"9","author":"Li","year":"2018","journal-title":"Cell death & disease"},{"key":"10.1016\/j.phrs.2019.03.011_bib0165","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3389\/fphar.2017.00823","article-title":"Identification of a New Potent Inhibitor Targeting KRAS in Non-small Cell Lung Cancer Cells","volume":"8","author":"Xie","year":"2017","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.phrs.2019.03.011_bib0170","doi-asserted-by":"crossref","first-page":"522","DOI":"10.7150\/ijbs.4164","article-title":"TWIST represses estrogen receptor-alpha expression by recruiting the NuRD protein complex in breast cancer cells","volume":"8","author":"Fu","year":"2012","journal-title":"International journal of biological sciences"},{"issue":"56","key":"10.1016\/j.phrs.2019.03.011_bib0175","doi-asserted-by":"crossref","first-page":"96089","DOI":"10.18632\/oncotarget.21716","article-title":"Novel direct AMPK activator suppresses non-small cell lung cancer through inhibition of lipid metabolism","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.phrs.2019.03.011_bib0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-017-0065-9","article-title":"Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity","volume":"9","author":"Leung","year":"2018","journal-title":"Cell death & disease"},{"issue":"10","key":"10.1016\/j.phrs.2019.03.011_bib0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0998-7","article-title":"Arsenic circumvents the gefitinib resistance by binding to P62 and mediating autophagic degradation of EGFR in non-small cell lung cancer","volume":"9","author":"Mao","year":"2018","journal-title":"Cell death & disease"},{"key":"10.1016\/j.phrs.2019.03.011_bib0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jchromb.2016.01.006","article-title":"Simultaneous determination of gefitinib and its major metabolites in mouse plasma by HPLC\u2013MS\/MS and its application to a pharmacokinetics study","volume":"1011","author":"Zheng","year":"2016","journal-title":"Journal of Chromatography B"},{"issue":"4","key":"10.1016\/j.phrs.2019.03.011_bib0195","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1747-0285.2010.01019.x","article-title":"Research Article: Binding of Cordycepin Monophosphate to AMP-Activated Protein Kinase and its Effect on AMP-Activated Protein Kinase Activation","volume":"76","author":"Wang","year":"2010","journal-title":"Chemical Biology & Drug Design banner"},{"issue":"4","key":"10.1016\/j.phrs.2019.03.011_bib0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.bcp.2011.05.016","article-title":"Compound C stimulates heme oxygenase-1 gene expression via the Nrf2-ARE pathway to preserve human endothelial cell survival","volume":"82","author":"Liu","year":"2011","journal-title":"Biochemical pharmacology"},{"key":"10.1016\/j.phrs.2019.03.011_bib0205","article-title":"Exploring the molecular mechanisms of Traditional Chinese Medicine components using gene expression signatures and connectivity map","author":"Yoo","year":"2018","journal-title":"Computer Methods and Programs in Biomedicine"},{"key":"10.1016\/j.phrs.2019.03.011_bib0210","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jep.2018.02.020","article-title":"Enhanced anticancer effects of Scutellaria barbata D. Don in combination with traditional Chinese medicine components on non-small cell lung cancer cells","volume":"217","author":"Wang","year":"2018","journal-title":"Journal of Ethnopharmacology"},{"issue":"4","key":"10.1016\/j.phrs.2019.03.011_bib0215","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.apsb.2018.04.005","article-title":"Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective","volume":"8","author":"Jiang","year":"2018","journal-title":"Acta pharmaceutica Sinica. B"},{"key":"10.1016\/j.phrs.2019.03.011_bib0220","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10912","article-title":"Structural basis of allosteric and synergistic activation of AMPK by furan-2-phosphonic derivative C2 binding","volume":"7","author":"Langendorf","year":"2016","journal-title":"Nature communications"},{"issue":"1","key":"10.1016\/j.phrs.2019.03.011_bib0225","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbrc.2004.06.133","article-title":"AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms","volume":"321","author":"Xiang","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.phrs.2019.03.011_bib0230","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.redox.2017.11.012","article-title":"Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS\/NF\u03baB\/mTOR\/P70S6K signaling cascade","volume":"14","author":"Lu","year":"2017","journal-title":"Redox biology"},{"issue":"10","key":"10.1016\/j.phrs.2019.03.011_bib0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139644","article-title":"mTOR Activation by PI3K\/Akt and ERK Signaling in Short ELF-EMF Exposed Human Keratinocytes","volume":"10","author":"Patruno","year":"2015","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.phrs.2019.03.011_bib0240","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-pharmtox-010611-134537","article-title":"AMPK and mTOR in Cellular Energy Homeostasis and Drug Targets","volume":"52","author":"Inoki","year":"2012","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"1","key":"10.1016\/j.phrs.2019.03.011_bib0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/jcmm.12001","article-title":"Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development","volume":"17","author":"Jain","year":"2013","journal-title":"Journal of cellular and molecular medicine"},{"issue":"7","key":"10.1016\/j.phrs.2019.03.011_bib0250","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1074\/jbc.M705232200","article-title":"Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress","volume":"283","author":"Okoshi","year":"2008","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.phrs.2019.03.011_bib0255","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34156-6","article-title":"The protective effects of maltol on cisplatin-induced nephrotoxicity through the AMPK-mediated PI3K\/Akt and p53 signaling pathways","volume":"8","author":"Mi","year":"2018","journal-title":"Scientific reports"},{"issue":"6","key":"10.1016\/j.phrs.2019.03.011_bib0260","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/onc.2015.134","article-title":"H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAK","volume":"35","author":"Olcina","year":"2016","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.phrs.2019.03.011_bib0265","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00709-013-0548-1","article-title":"P53 protein in proliferation, repair and apoptosis of cells","volume":"251","author":"Wawryk-Gawda","year":"2014","journal-title":"Protoplasma"},{"issue":"9","key":"10.1016\/j.phrs.2019.03.011_bib0270","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nature cell biology"},{"key":"10.1016\/j.phrs.2019.03.011_bib0275","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature23880","article-title":"Competing memories of mitogen and p53 signalling control cell-cycle entry","volume":"549","author":"Yang","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phrs.2019.03.011_bib0280","first-page":"21","article-title":"Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum","volume":"35","author":"C. Centers for Disease","year":"1986","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.phrs.2019.03.011_bib0285","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.phrs.2019.03.011_bib0290","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1470-2045(13)70604-1","article-title":"Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial","volume":"15","author":"Wu","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.phrs.2019.03.011_bib0295","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.lungcan.2018.07.031","article-title":"Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations","volume":"124","author":"Uchibori","year":"2018","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.phrs.2019.03.011_bib0300","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.cllc.2018.05.007","article-title":"Gefitinib Versus Adjuvant Chemotherapy in Patients With Stage II-IIIA Non-Small-Cell Lung Cancer Harboring Positive EGFR Mutations: A Single-Center Retrospective Study","volume":"19","author":"Xie","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.phrs.2019.03.011_bib0305","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.critrevonc.2016.01.024","article-title":"Resistance mechanisms after tyrosine kinase inhibitors afatinib and crizotinib in non-small cell lung cancer, a review of the literature","volume":"100","author":"van der Wekken","year":"2016","journal-title":"Critical Reviews in Oncology\/Hematology"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819301732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819301732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T01:43:30Z","timestamp":1565142210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661819301732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":61,"alternative-id":["S1043661819301732"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.03.011","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cordycepin Inhibits Drug-resistance Non-small Cell Lung Cancer Progression by Activating AMPK Signaling Pathway","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}